Hypertension, pulmonary Trials in Cincinnati, United States
Conditions / Hypertension, pulmonary / Cincinnati, United States
Research into Hypertension, pulmonary spans multiple therapeutic approaches and trial phases.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00016523 | Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure | TERMINATED | PHASE3 |
| NCT03626688 | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients | COMPLETED | — |
| NCT03683186 | A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | ENROLLING_BY_INVITATION | PHASE3 |
| NCT04193046 | A Study for the Identification of Biomarker Signatures for Early Detection of Pulmonary Hypertension (PH) | COMPLETED | EARLY_PHASE1 |
| NCT04945460 | A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16) | COMPLETED | — |
| NCT02191137 | Measuring Outcomes In Patients With Pulmonary Arterial Hypertension Not on Active Treatment (MOTION) | COMPLETED | PHASE4 |
| NCT04175600 | A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01065454 | A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction | COMPLETED | PHASE2 |
| NCT06814145 | Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023) | RECRUITING | PHASE2 |
| NCT01178073 | A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) | COMPLETED | PHASE3 |